Astma klinikiniai tyrimai Džordžija
7 tyrimai dėl Astma ieško dalyvių vietose Džordžija.
Miestai Džordžija
Oficialus tyrimo tekstas (anglų kalba)
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Albany
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07301255A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Cpcc-Research Llc, East Point
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06977581A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Research Site, Atlanta
Renkami dalyviai3 fazė
Amžius nuo 5 iki 11 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06023589A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 18, Rincon
Renkami dalyviai3 fazė
Amžius nuo 12 iki 80 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07276724A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12175, Conyers
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT06664619Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Atlanta
- Research Site, Columbus
- Research Site, Fayetteville
- ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-08-13 · NCT06307665Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
- AllerVie Clinical Research, Columbus
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 5 iki 100 · Visoms lytims · Atnaujinta 2026-06-02 · NCT07228026Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.